Research Paper Volume 15, Issue 17 pp 9086—9104
Integrated clustering signature of genomic heterogeneity, stemness and tumor microenvironment predicts glioma prognosis and immunotherapy response
Figure 5. Construction of the risk score signature. (A) Distribution of the risk score, survival status, and expression profile of the prognostic genes in the TCGA cohort. (B) Kaplan-Meier curves displaying prognostic differences between high and low-risk groups in the TCGA cohort. (C) The ROC curves describing the sensitivity and specificity of the risk score in predicting OS at 1-, 3- and 5-year time points in the TCGA cohort. (D) Distribution of the risk score, survival status, and expression profile of the prognostic genes in the CGGA cohort. (E) Kaplan-Meier curves displaying prognostic differences between high and low-risk groups in the CGGA cohort. (F) The ROC curves describing the sensitivity and specificity of the risk score in predicting OS at 1-, 3- and 5-year time points in the CGGA cohort.